Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment
A Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Before and After Treatment With Desvenlafaxine
Sponsor: Unity Health Toronto
A PHASE4 clinical study on Anhedonia and Depression, this trial is completed. The trial is conducted by Unity Health Toronto and has accumulated 10 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 5 earlier versions
-
Nov 2019 — Dec 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2019 [monthly]
Recruiting PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2017 — Oct 2017 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Unity Health Toronto
For direct contact, visit the study record on ClinicalTrials.gov .